Literature DB >> 12721286

A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5.

Michele Yeo1, Patrick S Lin, Michael E Dahmus, Gordon N Gill.   

Abstract

The transcription and processing of pre-mRNA in eukaryotic cells are regulated in part by reversible phosphorylation of the C-terminal domain of the largest RNA polymerase (RNAP) II subunit. The CTD phosphatase, FCP1, catalyzes the dephosphorylation of RNAP II and is thought to play a major role in polymerase recycling. This study describes a family of small CTD phosphatases (SCPs) that preferentially catalyze the dephosphorylation of Ser5 within the consensus repeat. The preferred substrate for SCP1 is RNAP II phosphorylated by TFIIH. Like FCP1, the activity of SCP1 is enhanced by the RAP74 subunit of TFIIF. Expression of SCP1 inhibits activated transcription from a number of promoters, whereas a phosphatase-inactive mutant of SCP1 enhances transcription. Accordingly, SCP1 may play a role in the regulation of gene expression, possibly by controlling the transition from initiation/capping to processive transcript elongation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721286     DOI: 10.1074/jbc.M301791200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

1.  Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

2.  Fcp1 directly recognizes the C-terminal domain (CTD) and interacts with a site on RNA polymerase II distinct from the CTD.

Authors:  Man-Hee Suh; Ping Ye; Mincheng Zhang; Stéphane Hausmann; Stewart Shuman; Averell L Gnatt; Jianhua Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

3.  Cellular splicing and transcription regulatory protein p32 represses adenovirus major late transcription and causes hyperphosphorylation of RNA polymerase II.

Authors:  Christina Ohrmalm; Göran Akusjärvi
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription.

Authors:  James Thompson; Tatyana Lepikhova; Neus Teixido-Travesa; Maria A Whitehead; Jorma J Palvimo; Olli A Jänne
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

5.  Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

Authors:  Nathan P Gomes; Glen Bjerke; Briardo Llorente; Stephanie A Szostek; Beverly M Emerson; Joaquin M Espinosa
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

6.  Expression and characterization of HSPC129, a RNA polymerase II C-terminal domain phosphatase.

Authors:  Hui Qian; Chaoneng Ji; Shuo Zhao; Jinzhong Chen; Mei Jiang; Yong Zhang; Mi Yan; Dan Zheng; Yaqiong Sun; Yi Xie; Yumin Mao
Journal:  Mol Cell Biochem       Date:  2007-05-09       Impact factor: 3.396

Review 7.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

Review 8.  RNA polymerase II transcription elongation control.

Authors:  Jiannan Guo; David H Price
Journal:  Chem Rev       Date:  2013-08-06       Impact factor: 60.622

9.  Arabidopsis C-terminal domain phosphatase-like 1 and 2 are essential Ser-5-specific C-terminal domain phosphatases.

Authors:  Hisashi Koiwa; Stéphane Hausmann; Woo Young Bang; Akihiro Ueda; Naoko Kondo; Akihiro Hiraguri; Toshiyuki Fukuhara; Jeong Dong Bahk; Dae-Jin Yun; Ray A Bressan; Paul M Hasegawa; Stewart Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-23       Impact factor: 11.205

Review 10.  How eukaryotic genes are transcribed.

Authors:  Bryan J Venters; B Franklin Pugh
Journal:  Crit Rev Biochem Mol Biol       Date:  2009-06       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.